ESR1 and benign neoplasm: Furthermore, the presence of estrogen receptors in benign tumors implies that these tumors may respond to hormonal fluctuations, potentially leading to increased growth rates during periods of elevated estrogen levels, such as during pregnancy or hormone replacement therapy.